Sponsored by:

Lantheus to sell 5M shares of stock

Lantheus Holdings, parent company of Lantheus Medical Imaging, said it plans to sell 5.2 million shares of common stock in a public offering.

The company will use the proceeds along with cash on hand to pay down approximately $55 million of an outstanding principal balance under its senior secured credit facilities.

Credit Suisse and Jefferies will act as underwriters for the stock offering, Lantheus said.

Latest in Nuclear Medicine
Page 1 of 440
Next Page